US · Healthcare

Shanghai Junshi Biosciences Co. Ltd (SHJBF)

Biotechnology

Shanghai Junshi Biosciences Co. Ltd (SHJBF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SHJBF

P/E ratio

25.00

Shanghai Junshi Biosciences Co. Ltd (SHJBF) — FAQ

What is SHJBF's P/E ratio?

The price-to-earnings (P/E) ratio for Shanghai Junshi Biosciences Co. Ltd (SHJBF) is 25.00 (data as of 2026-05-23).

Does Shanghai Junshi Biosciences Co. Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Shanghai Junshi Biosciences Co. Ltd (SHJBF). Check the MyAverix Finance app for the latest dividend data.

What sector is Shanghai Junshi Biosciences Co. Ltd in?

Shanghai Junshi Biosciences Co. Ltd (SHJBF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SHJBF listed on?

SHJBF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)